开能健康
(300272)
| 流通市值：27.72亿 | | | 总市值：37.12亿 |
| 流通股本：4.31亿 | | | 总股本：5.77亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 405,475,102.35 | 1,688,500,855.6 | 1,254,037,408.51 | 829,329,438.24 |
| 营业收入 | 405,475,102.35 | 1,688,500,855.6 | 1,254,037,408.51 | 829,329,438.24 |
| 利息收入 | 0 | 0 | 0 | 0 |
| 已赚保费 | 0 | 0 | 0 | 0 |
| 手续费及佣金收入 | 0 | 0 | 0 | 0 |
| 二、营业总成本 | 355,567,191.64 | 1,520,920,924.29 | 1,111,772,648.37 | 725,826,780.47 |
| 营业成本 | 238,717,953.09 | 1,030,027,765.54 | 749,111,152.64 | 493,431,858.34 |
| 利息支出 | 0 | 0 | 0 | 0 |
| 手续费及佣金支出 | 0 | 0 | 0 | 0 |
| 退保金 | 0 | 0 | 0 | 0 |
| 赔付支出净额 | 0 | 0 | 0 | 0 |
| 提取保险合同准备金净额 | 0 | 0 | 0 | 0 |
| 保单红利支出 | 0 | 0 | 0 | 0 |
| 分保费用 | 0 | 0 | 0 | 0 |
| 税金及附加 | 2,895,458.69 | 9,733,187.57 | 7,262,279.14 | 4,747,484.79 |
| 销售费用 | 41,146,634.66 | 182,058,186.29 | 127,099,317.68 | 85,280,827.21 |
| 管理费用 | 55,281,862.91 | 234,685,375.11 | 170,691,341.04 | 113,180,931.02 |
| 研发费用 | 13,595,783.93 | 68,479,784.71 | 46,343,257.83 | 31,495,834 |
| 财务费用 | 3,929,498.36 | -4,063,374.93 | 11,265,300.04 | -2,310,154.89 |
| 其中:利息费用 | 7,856,852.94 | 34,481,856.51 | 24,916,994.92 | 17,026,777.64 |
| 其中:利息收入 | 3,484,385.2 | 22,548,261.47 | 14,786,429.82 | 10,522,184.19 |
| 加:公允价值变动收益 | -32,140.68 | -3,001,349.41 | 2.76 | 1.82 |
| 加:投资收益 | -9,017,868.73 | -30,496,289.09 | -14,765,202.52 | -13,658,795.66 |
| 净敞口套期收益 | 0 | 0 | 0 | 0 |
| 汇兑收益 | 0 | 0 | 0 | 0 |
| 资产处置收益 | 0 | -112,753.26 | 117,802.71 | 11,290.87 |
| 资产减值损失(新) | 23,259.67 | -7,056,956.98 | -1,503,090.92 | -1,961,231.9 |
| 信用减值损失(新) | 237,547.44 | -1,412,518.88 | 251,463.97 | 203,406.17 |
| 其他收益 | 2,168,061.6 | 14,577,541.46 | 6,851,813.3 | 5,781,345 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 43,286,770.01 | 140,077,605.15 | 133,217,549.44 | 93,878,674.07 |
| 加:营业外收入 | 0.1 | 1,064,689.08 | 366,558.68 | 158,328.96 |
| 减:营业外支出 | 327,642.44 | 6,138,129.86 | 1,294,728.07 | 712,532.41 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 42,959,127.67 | 135,004,164.37 | 132,289,380.05 | 93,324,470.62 |
| 减:所得税费用 | 9,022,703.02 | 21,555,280.07 | 22,646,313.16 | 20,128,260.22 |
| 六、净利润 | 33,936,424.65 | 113,448,884.3 | 109,643,066.89 | 73,196,210.4 |
| 持续经营净利润 | 33,936,424.65 | 113,448,884.3 | 109,643,066.89 | 73,196,210.4 |
| 终止经营净利润 | 0 | 0 | 0 | 0 |
| 归属于母公司股东的净利润 | 24,810,870.17 | 83,575,721.82 | 84,165,039.65 | 57,031,840.79 |
| 少数股东损益 | 9,125,554.48 | 29,873,162.48 | 25,478,027.24 | 16,164,369.61 |
| (一)基本每股收益 | 0.04 | 0.15 | 0.15 | 0.1 |
| (二)稀释每股收益 | 0.04 | 0.14 | 0.14 | 0.1 |
| 八、其他综合收益 | -1,516,723.68 | -185,850.71 | -2,497,310.3 | 136,998.43 |
| 归属于母公司股东的其他综合收益 | -1,291,929.64 | 342,561.9 | -2,175,159.93 | -149,804.34 |
| 九、综合收益总额 | 32,419,700.97 | 113,263,033.59 | 107,145,756.59 | 73,333,208.83 |
| 归属于母公司股东的综合收益总额 | 23,518,940.53 | 83,918,283.72 | 81,989,879.72 | 56,882,036.45 |
| 归属于少数股东的综合收益总额 | 8,900,760.44 | 29,344,749.87 | 25,155,876.87 | 16,451,172.38 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-29 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |